Security key
89680M101
TriSalus Life Sciences, Inc. - Common Stock, Par Value $0.0001 per share (TLSI)
CUSIP: 89680M101
Q3 2023 13F Holders as of 30 Sep 2023
- Security type / class
- Equity / Common Stock, Par Value $0.0001 per share
- Total 13F shares
- 136,575
- Total 13F value
- $699,263
- Share change
- +136,575
- SEC-reported price per share
- $5.12
- Number of holders
- 9
- Value change
- +$699,263
- Number of buys
- 9
- Shares outstanding
- 61,321,365
Holder snapshot
5 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q3 2023
Institutions
9
Top holders
9
TLSI full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q4 2023
TriSalus Life Sciences, Inc. SEC filings
TriSalus Life Sciences, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 89680M101
Recent filing periods:
Ownership snapshot
Top reported holders of TLSI - TriSalus Life Sciences, Inc. - Common Stock, Par Value $0.0001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
MedTech Acquisition Spons...
Disclosed value leader
MedTech Acquisition Spons...
Comparable rows
0/3
Latest evidence
10 Aug 2023
3/4/5
Highest disclosed value: $65,538,115
3 rows are not safely comparable across share classes.
Quick read
MedTech Acquisition Sponsor LLC has the largest disclosed position value at $65.54M.
0 of 3 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens MedTech Acquisition Sponsor LLC's linked filing trail.
Disclosed position value
Top 3
MedTech Acquisition Sponsor LLC
$65.54M
Magnetar Financial LLC
$174.8K
James Alecxih
$521.1K
Value bars compare disclosed positions; verify each figure against the linked filing evidence.
Detailed SEC evidence table Showing 1-3 of 3 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| MedTech Acquisition Sponsor LLC |
3/4/5
10%+ Owner
|
—
mixed-class rows
|
$65,538,115
6,250,000 shares
mixed-class rows
|
— | 26 Jun 2023 |
| Magnetar Financial LLC |
3/4/5
10%+ Owner
|
—
class O/S missing
|
$174,782
16,668 shares
|
— | 12 Jun 2023 |
| James Alecxih |
3/4/5
President, Device Technology
|
—
class O/S missing
|
$521,147
94,754 shares
|
— | 10 Aug 2023 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q3 2023
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
9
Shares
136,575
Rows available
9
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q3 2023 vs Q4 2025 Across Filers
Q4 2025 holders
63
Q3 2023 holders
9
Holder diff
-54
| Investor | Q4 2025 Shares | Q3 2023 Shares | Share Diff | Share Chg % | Q4 2025 value | Q3 2023 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend